Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001209191-21-036798

Director sold 11,064 shares at an average $18.68 ($206,701)

  • Director acquired 39,094 shares (option exercise)
  • Director gave up 6,418 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
HOLLER FRANK A Director 2021-05-27 Option exercise +3,086 $3.76 $11,603 125,127 D: show line 1 in the form
HOLLER FRANK A Director 2021-05-27 Shares withheld for taxes −507 $18.88 $9,572 124,620 D: show line 2 in the form
HOLLER FRANK A Director 2021-05-27 Option exercise +36,008 $3.76 $135,390 160,628 D: show line 3 in the form
HOLLER FRANK A Director 2021-05-27 Shares withheld for taxes −5,911 $18.88 $111,600 154,717 D: show line 4 in the form
HOLLER FRANK A Director 2021-05-27 Sale −2,579 $18.69 $48,202 152,138 D: show line 5 in the form
HOLLER FRANK A Director 2021-05-27 Sale −8,485 $18.68 $158,500 143,653 D: show line 6 in the form
Open-market sales · 11,064 sh · avg $18.68 · $206,701

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
HOLLER FRANK A Director 2021-05-27 Option exercise · Stock Option (Right to Buy) −3,086 0 D: show line 7 in the form
HOLLER FRANK A Director 2021-05-27 Option exercise · Stock Option (Right to Buy) −36,008 0 D: show line 8 in the form
Loading xslF345X03/doc4.xml…